World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
143
Citations
91834
World Ranking
1487
National Ranking
864

Overview

Harry V. Vinters is affiliated with the University of California, Los Angeles in the United States. Their research primarily covers the field of Medicine, with an emphasis on Neurology, Molecular Biology, Physiology, Endocrinology, Diabetes and Metabolism, and Genetics.

The scientist's work spans a variety of topics, including:

  • Alzheimer's disease research and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Pituitary Gland Disorders and Treatments
  • Neurological Disease Mechanisms and Treatments
  • Glioma Diagnosis and Treatment
  • Parkinson's Disease Mechanisms and Treatments

Harry V. Vinters has published extensively in several venues. The most frequent publication outlets include:

  • Journal of the Endocrine Society
  • Journal of Neuropathology & Experimental Neurology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • PubMed
  • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

The scientist collaborates regularly with colleagues such as Shino Magaki, Christopher Kazu Williams, William H. Yong, Marvin Bergsneider, and Christopher Kwesi O. Williams.

Selected recent papers by Harry V. Vinters include:

  • Brain arteriolosclerosis, 2020, Acta Neuropathologica
  • Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro, 2022, Nature Communications
  • Neuropathology of COVID-19 (neuro-COVID): clinicopathological update, 2020, PubMed
  • Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein, 2023, Nature Neuroscience
  • Inhibition of synucleinopathic seeding by rationally designed inhibitors, 2020, eLife

Best Publications

  • Astrocytes: biology and pathology

    Michael V. Sofroniew;Harry V. Vinters

  • An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

    Ralph L. Sacco;Scott E. Kasner;Joseph P. Broderick;Louis R. Caplan

  • National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

    Bradley T. Hyman;Creighton H. Phelps;Thomas G. Beach;Eileen H. Bigio

  • National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

    Thomas J. Montine;Creighton H. Phelps;Thomas G. Beach;Eileen H. Bigio

  • National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards

    Vladimir Hachinski;Costantino Iadecola;Ron C. Petersen;Monique M. Breteler

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission

    Ingmar Blümcke;Maria Thom;Eleonora Aronica;Dawna D. Armstrong

  • Mitochondrial abnormalities in Alzheimer's disease.

    Keisuke Hirai;Gjumrakch Aliev;Akihiko Nunomura;Akihiko Nunomura;Hisashi Fujioka

  • Cerebral amyloid angiopathy. A critical review.

    H V Vinters

  • Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy: A Randomized Trial

    Jerome Engel;Michael P. McDermott;Samuel Wiebe;John T. Langfitt

  • Terminology and classification of the cortical dysplasias.

    André Palmini;Imad Najm;G. Avanzini;T. Babb

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

    Yoshio Koyanagi;Steven Miles;Ronald T. Mitsuyasu;Jean E. Merrill

  • PET of Brain Amyloid and Tau in Mild Cognitive Impairment

    Gary W. Small;Vladimir Kepe;Linda M. Ercoli;Prabha Siddarth

  • Alzheimer's disease Etiologies, pathophysiology, cognitive reserve, and treatment opportunities

    Jeffrey L. Cummings;Harry V. Vinters;Gregory M. Cole;Zaven S. Khachaturian

  • Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

    Vivianna M. Van Deerlin;Patrick M A Sleiman;Maria Martinez-Lage;Maria Martinez-Lage;Alice Chen-Plotkin

  • Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

    H V Vinters;J J Gilbert

  • Cerebral Cortical Dysplasia Associated with Pediatric Epilepsy. Review of Neuropathologic Features and Proposal for a Grading System

    Paul S. Mischel;Loan P. Nguyen;Harry V. Vinters

  • Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy: A Randomized Trial

    Jerome Engel;Michael P. Mcdermott;Samuel Wiebe;John T. Langfitt

  • An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Endorsed by the American Association of Neurological Surgeons and Congress of Neurological Surgeons

    Ralph L. Sacco;Scott E. Kasner;Joseph P. Broderick;Louis R. Caplan

Frequent Co-Authors

Gary W. Mathern
Gary W. Mathern University of California, Los Angeles
Carlos Cepeda
Carlos Cepeda University of California, Los Angeles
Helena C. Chui
Helena C. Chui University of Southern California
Fernando Vinuela
Fernando Vinuela University of California, Los Angeles
Paul S. Mischel
Paul S. Mischel Stanford University
Michael S. Levine
Michael S. Levine Princeton University
Véronique M. André
Véronique M. André UCB Pharma (Belgium)
John Q. Trojanowski
John Q. Trojanowski University of Pennsylvania
Jeffrey L. Cummings
Jeffrey L. Cummings University of Nevada, Las Vegas

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up a range of related online degree programs and career pathways. For those seeking to advance in specialized fields, accelerated options like shortest post master's pmhnp online programs help practitioners quickly qualify as Psychiatric Mental Health Nurse Practitioners. These courses are ideal for working professionals who want to expand clinical skills without a lengthy time commitment.

Interested in the administrative side of healthcare? There are high-quality, affordable healthcare administration degree online options for those looking to build management expertise. Additionally, understanding the cost of mha degree programs can help you make informed decisions about pursuing a master's in healthcare administration.

For nurses aiming for leadership or academic roles, achieving a Doctor of Nursing Practice (DNP) is a significant milestone — explore the cheapest dnp program choices available to minimize costs while maximizing career potential.

Best Scientists Citing Harry V. Vinters

Trending Scientists